Kehua Bio-Engineering subsidiary secures new diagnostic kit registrations

Shanghai Kehua Bio-Engineering announced that its subsidiary Suzhou Tianlong Bio-Technology has obtained medical device registration certificates for two diagnostic kits.

The newly registered products include a Respiratory Syncytial Virus detection kit and a Respiratory Adenovirus detection kit, both using fluorescent PCR methods for detecting viral nucleic acids in human throat swab samples.

The registrations are valid until July 2030 and expand the company's diagnostic product portfolio.